Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-016824
Filing Date
2019-05-08
Accepted
2019-05-08 07:13:38
Documents
116
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hznp-10q_20190331.htm 10-Q 3363530
2 EX-3.1 ex31.htm EX-3.1 390729
3 EX-10.2 ex102.htm EX-10.2 82763
4 EX-10.3 ex103.htm EX-10.3 397458
5 EX-10.4 ex104.htm EX-10.4 323284
6 EX-10.5 ex105.htm EX-10.5 358182
7 EX-10.6 ex106.htm EX-10.6 67728
8 EX-10.7 ex107.htm EX-10.7 371833
9 EX-10.8 ex108.htm EX-10.8 205968
10 EX-18.1 hznp-ex181_1073.htm EX-18.1 6591
11 EX-31.1 hznp-ex311_1072.htm EX-31.1 15951
12 EX-31.2 hznp-ex312_1071.htm EX-31.2 15837
13 EX-32.1 hznp-ex321_1070.htm EX-32.1 8903
14 EX-32.2 hznp-ex322_1069.htm EX-32.2 8924
15 GRAPHIC g725917page1.jpg GRAPHIC 5017
  Complete submission text file 0001564590-19-016824.txt   15374286

Data Files

Seq Description Document Type Size
16 XBRL INSTANCE DOCUMENT hznp-20190331.xml EX-101.INS 3048454
17 XBRL TAXONOMY EXTENSION SCHEMA hznp-20190331.xsd EX-101.SCH 103111
18 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hznp-20190331_cal.xml EX-101.CAL 75279
19 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hznp-20190331_def.xml EX-101.DEF 449001
20 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20190331_lab.xml EX-101.LAB 674632
21 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20190331_pre.xml EX-101.PRE 619169
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35238 | Film No.: 19805147
SIC: 2834 Pharmaceutical Preparations